Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study

INTRODUCTION: Parkinson’s disease (PD) is a progressive neurodegenerative condition affecting approximately 185,000 people in the UK. No drug has been proven to slow disease progression. Epidemiological and pre-clinical data support simvastatin, a widely used cholesterol-lowering drug with a well-es...

Descripción completa

Detalles Bibliográficos
Autores principales: Carroll, Camille B, Webb, Douglas, Stevens, Kara Nicola, Vickery, Jane, Eyre, Vicky, Ball, Susan, Wyse, Richard, Webber, Mike, Foggo, Andy, Zajicek, John, Whone, Alan, Creanor, Siobhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797358/
https://www.ncbi.nlm.nih.gov/pubmed/31594876
http://dx.doi.org/10.1136/bmjopen-2019-029740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797358/
https://www.ncbi.nlm.nih.gov/pubmed/31594876
http://dx.doi.org/10.1136/bmjopen-2019-029740

Ejemplares similares